Literature DB >> 11802791

S2' substrate specificity and the role of His110 and His111 in the exopeptidase activity of human cathepsin B.

Joanne C Krupa1, Sadiq Hasnain, Dorit K Nägler, Robert Ménard, John S Mort.   

Abstract

The ability of the lysosomal cysteine protease cathepsin B to function as a peptidyldipeptidase (removing C-terminal dipeptides) has been attributed to the presence of two histidine residues (His(110) and His(111)) present in the occluding loop, an extra peptide segment located in the primed side of the active-site cleft. Whereas His(111) is unpaired, His(110) is present as an ion pair with Asp(22) on the main body of the protease. This ion pair appears to act as a latch to hold the loop in a closed position. The exopeptidase activity of cathepsin B, examined using quenched fluorescence substrates, was shown to have a 20-fold preference for aromatic side chains in the P2' position relative to glutamic acid as the least favourable residue. Site-directed mutagenesis demonstrated that His(111) makes a positive 10-fold contribution to the exopeptidase activity, whereas His(110) is critical for this action with the Asp(22)-His(110) ion pair stabilizing the electrostatic interaction by a maximum of 13.9 kJ/mol (3.3 kcal/mol). These studies showed that cathepsin B is optimized to act as an exopeptidase, cleaving dipeptides from protein substrates in a successive manner, because of its relaxed specificity in P2' and its other subsites.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11802791      PMCID: PMC1222344          DOI: 10.1042/0264-6021:3610613

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

Review 1.  Cathepsin B.

Authors:  J S Mort; D J Buttle
Journal:  Int J Biochem Cell Biol       Date:  1997-05       Impact factor: 5.085

2.  Stoichiometry and heterogeneity of the pro-region chain in tetrameric human cathepsin C.

Authors:  B Cigić; I Krizaj; B Kralj; V Turk; R H Pain
Journal:  Biochim Biophys Acta       Date:  1998-01-15

3.  Two-step mechanism of inhibition of cathepsin B by cystatin C due to displacement of the proteinase occluding loop.

Authors:  M Nycander; S Estrada; J S Mort; M Abrahamson; I Björk
Journal:  FEBS Lett       Date:  1998-01-23       Impact factor: 4.124

4.  Role of the occluding loop in cathepsin B activity.

Authors:  C Illy; O Quraishi; J Wang; E Purisima; T Vernet; J S Mort
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

5.  Crystal structure of the wild-type human procathepsin B at 2.5 A resolution reveals the native active site of a papain-like cysteine protease zymogen.

Authors:  M Podobnik; R Kuhelj; V Turk; D Turk
Journal:  J Mol Biol       Date:  1997-09-05       Impact factor: 5.469

6.  Binding mode of CA074, a specific irreversible inhibitor, to bovine cathepsin B as determined by X-ray crystal analysis of the complex.

Authors:  A Yamamoto; T Hara; K Tomoo; T Ishida; T Fujii; Y Hata; M Murata; K Kitamura
Journal:  J Biochem       Date:  1997-05       Impact factor: 3.387

7.  Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts.

Authors:  D K Nägler; A C Storer; F C Portaro; E Carmona; L Juliano; R Ménard
Journal:  Biochemistry       Date:  1997-10-14       Impact factor: 3.162

8.  Crystal structure of porcine cathepsin H determined at 2.1 A resolution: location of the mini-chain C-terminal carboxyl group defines cathepsin H aminopeptidase function.

Authors:  G Guncar; M Podobnik; J Pungercar; B Strukelj; V Turk; D Turk
Journal:  Structure       Date:  1998-01-15       Impact factor: 5.006

9.  Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme.

Authors:  D Brömme; K Okamoto; B B Wang; S Biroc
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

10.  Characterization of the S3 subsite specificity of cathepsin B.

Authors:  A Taralp; H Kaplan; I I Sytwu; I Vlattas; R Bohacek; A K Knap; T Hirama; C P Huber; S Hasnain
Journal:  J Biol Chem       Date:  1995-07-28       Impact factor: 5.157

View more
  16 in total

1.  Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni.

Authors:  Adéla Jílková; Pavlína Rezácová; Martin Lepsík; Martin Horn; Jana Váchová; Jindrich Fanfrlík; Jirí Brynda; James H McKerrow; Conor R Caffrey; Michael Mares
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

2.  Autocatalytic Processing and Substrate Specificity of Arabidopsis Chloroplast Glutamyl Peptidase.

Authors:  Nazmul H Bhuiyan; Elden Rowland; Giulia Friso; Lalit Ponnala; Elena J S Michel; Klaas J van Wijk
Journal:  Plant Physiol       Date:  2020-07-06       Impact factor: 8.340

3.  Induction of cell death in neuroblastoma by inhibition of cathepsins B and L.

Authors:  Rita Colella; Guizhen Lu; Lisa Glazewski; Bruce Korant; Anjan Matlapudi; Matthew R England; Colin Craft; Christopher N Frantz; Robert W Mason
Journal:  Cancer Lett       Date:  2010-04-01       Impact factor: 8.679

4.  Analysis of substrate specificity and endopeptidyl activities of the cathepsin B-like proteinase from Helicoverpa armigera.

Authors:  Xiao-Fan Zhao; Jin-Xing Wang; Fei-Xue Li; Shinji Sueda; Hiroki Kondo
Journal:  Protein J       Date:  2005-05       Impact factor: 2.371

5.  Cathepsin B carboxydipeptidase specificity analysis using internally quenched fluorescent peptides.

Authors:  Maria Helena S Cezari; Luciano Puzer; Maria Aparecida Juliano; Adriana K Carmona; Luiz Juliano
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

6.  A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.

Authors:  Simone A Beckham; David Piedrafita; Carolyn I Phillips; Nirma Samarawickrema; Ruby H P Law; Peter M Smooker; Noelene S Quinsey; James A Irving; Deanne Greenwood; Steven H L Verhelst; Matthew Bogyo; Boris Turk; Theresa H Coetzer; Lakshmi C Wijeyewickrema; Terry W Spithill; Robert N Pike
Journal:  Int J Biochem Cell Biol       Date:  2009-02-20       Impact factor: 5.085

7.  Cloning and expression of the major secreted cathepsin B-like protein from juvenile Fasciola hepatica and analysis of immunogenicity following liver fluke infection.

Authors:  Ruby H P Law; Peter M Smooker; James A Irving; David Piedrafita; Rebecca Ponting; Nicholas J Kennedy; James C Whisstock; Robert N Pike; Terry W Spithill
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

8.  A double-headed cathepsin B inhibitor devoid of warhead.

Authors:  Patricia Schenker; Pietro Alfarano; Peter Kolb; Amedeo Caflisch; Antonio Baici
Journal:  Protein Sci       Date:  2008-09-16       Impact factor: 6.725

9.  How does heparin prevent the pH inactivation of cathepsin B? Allosteric mechanism elucidated by docking and molecular dynamics.

Authors:  Mauricio G S Costa; Paulo R Batista; Cláudio S Shida; Charles H Robert; Paulo M Bisch; Pedro G Pascutti
Journal:  BMC Genomics       Date:  2010-12-22       Impact factor: 3.969

10.  Profiling of proteolytic enzymes in the gut of the tick Ixodes ricinus reveals an evolutionarily conserved network of aspartic and cysteine peptidases.

Authors:  Daniel Sojka; Zdenek Franta; Martin Horn; Ondrej Hajdusek; Conor R Caffrey; Michael Mares; Petr Kopácek
Journal:  Parasit Vectors       Date:  2008-03-18       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.